|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
JSTOROA_on1334650665 |
| 003 |
OCoLC |
| 005 |
20231005004200.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
120410s2011 gw a obm 000 0 eng |
| 010 |
|
|
|a 2020718726
|
| 040 |
|
|
|a DLC
|b eng
|e pn
|e rda
|c DLC
|d OCLCF
|d JSTOR
|d SOI
|d ERL
|d TXR
|d ICN
|d VT2
|d UPM
|d YDX
|d OCLCO
|
| 019 |
|
|
|a 1079760293
|a 1084420229
|a 1224919407
|a 1235846368
|
| 020 |
|
|
|z 3832967079
|q pbk. : alk. paper
|
| 020 |
|
|
|z 9783832967079
|q pbk. : alk. paper
|
| 020 |
|
|
|a 9783845231037
|q (electronic bk.)
|
| 020 |
|
|
|a 3845231033
|q (electronic bk.)
|
| 029 |
1 |
|
|a AU@
|b 000065197652
|
| 035 |
|
|
|a (OCoLC)1334650665
|z (OCoLC)1079760293
|z (OCoLC)1084420229
|z (OCoLC)1224919407
|z (OCoLC)1235846368
|
| 037 |
|
|
|a 22573/ctv932md5
|b JSTOR
|
| 043 |
|
|
|a e------
|
| 050 |
0 |
0 |
|a KJE6201
|
| 072 |
|
7 |
|a LAW
|x 014000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 343.240721
|2 22
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Philipp, Marc P.
|
| 245 |
1 |
0 |
|a Intellectual property related generic defense strategies in the European pharmaceutical market :
|b implications of the EU Commission's sector inquiry from an IP, competition law and economic perspective /
|c Marc P. Philipp.
|
| 264 |
|
1 |
|a Baden-Baden :
|b Nomos,
|c 2011.
|
| 300 |
|
|
|a 1 electronic resource (91 pages ).
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|
| 380 |
|
|
|a Thesis
|
| 490 |
1 |
|
|a MIPLC studies ;
|v v. 11
|
| 500 |
|
|
|a "Munich Intellectual Property Law Center."
|
| 502 |
|
|
|a Thesis--Universität München, 2010.
|
| 504 |
|
|
|a Includes bibliographical references (pages 83-91).
|
| 505 |
0 |
|
|a Introduction -- Governance framework of Europe's pharmaceutical sector -- Competitive dynamics in Europe's pharmaceutical market -- Potential future limitations for generic defense -- Implications of business model transformations -- Conclusion and managerial recommendation.
|
| 588 |
|
|
|a Description based on print version record; resource not viewed.
|
| 590 |
|
|
|a JSTOR
|b Books at JSTOR Open Access
|
| 590 |
|
|
|a JSTOR
|b Books at JSTOR All Purchased
|
| 650 |
|
0 |
|a Antitrust law
|z European Union countries.
|
| 650 |
|
0 |
|a Drugs
|v Patents.
|
| 650 |
|
0 |
|a Drugs
|x Law and legislation
|z European Union countries.
|
| 650 |
|
0 |
|a Generic drugs
|z European Union countries.
|
| 650 |
|
6 |
|a Médicaments
|v Brevets d'invention.
|
| 650 |
|
6 |
|a Médicaments génériques
|z Pays de l'Union européenne.
|
| 650 |
|
7 |
|a LAW
|x Commercial
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a UE/CE Droit.
|2 eclas
|
| 650 |
|
7 |
|a Industrie pharmaceutique.
|2 eclas
|
| 650 |
|
7 |
|a Médicaments génériques.
|2 eclas
|
| 650 |
|
7 |
|a Propriété intellectuelle.
|2 eclas
|
| 650 |
|
7 |
|a Droit de la concurrence.
|2 eclas
|
| 650 |
|
7 |
|a Position dominante.
|2 eclas
|
| 650 |
|
7 |
|a Antitrust law
|2 fast
|
| 650 |
|
7 |
|a Drugs
|2 fast
|
| 650 |
|
7 |
|a Drugs
|x Law and legislation
|2 fast
|
| 650 |
|
7 |
|a Generic drugs
|2 fast
|
| 651 |
|
7 |
|a European Union countries
|2 fast
|
| 655 |
|
7 |
|a dissertations.
|2 aat
|
| 655 |
|
7 |
|a Patents
|2 fast
|
| 655 |
|
7 |
|a Academic theses.
|2 lcgft
|
| 655 |
|
7 |
|a Thèses et écrits académiques.
|2 rvmgf
|
| 710 |
2 |
|
|a Munich Intellectual Property Law Center.
|
| 776 |
0 |
8 |
|i Print version:
|t Intellectual property related generic defense strategies in the European pharmaceutical market
|d Baden-Baden : Nomos, 2011.
|z 9783832967079 (pbk. : alk. paper)
|w (DLC) 2012392191
|
| 830 |
|
0 |
|a MIPLC studies ;
|v v. 11.
|
| 856 |
4 |
0 |
|u https://jstor.uam.elogim.com/stable/10.2307/j.ctv941sfv
|z Texto completo
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 302849712
|
| 994 |
|
|
|a 92
|b IZTAP
|
